IL2 and cancer: The synergy between IL-2's immune amplification and IPCGOR's direct cytotoxicity results in a robust and comprehensive anti-cancer action.In terms of adverse events, our study observed a spectrum of reactions consistent with both chemotherapy and immunotherapy.